Martin Sebastian Olivo's most recent trade in Protara Therapeutics Inc was a trade of 4,959 Common Stock done at an average price of $10.1 . Disclosure was reported to the exchange on June 10, 2021.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Protara Therapeutics Inc | Martin Sebastian Olivo | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 10.08 per share. | 10 Jun 2021 | 4,959 | 9,410 (0%) | 0% | 10.1 | 49,987 | Common Stock |
| Protara Therapeutics Inc | Martin Sebastian Olivo | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 10.13 per share. | 10 Jun 2021 | 4,934 | 14,344 (0%) | 0% | 10.1 | 49,981 | Common Stock |
| Protara Therapeutics Inc | Martin Sebastian Olivo | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Apr 2021 | 120,000 | 120,000 | - | - | Stock Option (Right to Buy) |